Clinical Trials Browser

Phase 2 × Head and Neck Neoplasms × Thalidomide × Clear all

NCT00026533 2017-06-06

Thalidomide in Treating Patients With Thyroid Cancer

Phase 2 Completed

EndocrineHead & Neck

Thyroid Cancer, Papillary, Head and Neck Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary

NCT00003850 2013-02-08

Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Phase 2 Completed

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms